/

Other

/

Prothya Biosolutions

Prothya Biosolutions

Prothya Biosolutions

Verified Nov 2026

Other

·

Brussels, Brussels

·

Since 2021

Prothya Biosolutions is a European biotechnology company headquartered in Brussels, Belgium, founded in 2021 through the merger of Plasma Industries Belgium and Sanquin Plasma Products. The company employs 1,000–5,000 people and generates an estimated $100–250 million in revenue. It specializes in blood plasma collection, processing, and fractionation to produce plasma-derived medicinal products including albumin, immunoglobulins, and coagulation factors for medical, automotive, and industrial-equipment sectors. In October 2025, Accord Plasma B.V. acquired the company.

Prothya Biosolutions

Verified Nov 2026

AT A GLANCE

Founded

2021

Headquarters

Brussels, Brussels

Employees

1,000-5,000

Ownership

Prothya Biosolutions at a glance

Revenue

$100-250M

Est. band

Employees

1,000-5,000

Founded

2021

Headquarters

Brussels, Brussels

Industries

Automotive

Electric Vehicles

Medical

Industrial Equipment

Overview

Prothya Biosolutions is a European biotechnology company headquartered in Brussels, Belgium, founded in 2021 through the merger of Plasma Industries Belgium and Sanquin Plasma Products. The company employs 1,000–5,000 people and generates an estimated $100–250 million in revenue. It specializes in blood plasma collection, processing, and fractionation to produce plasma-derived medicinal products including albumin, immunoglobulins, and coagulation factors for medical, automotive, and industrial-equipment sectors. In October 2025, Accord Plasma B.V. acquired the company.

At a glance

Attribute

Detail

Founded

2021

Headquarters

Brussels, Brussels

Employees

1,000-5,000

Revenue

$100-250M (estimated)

What Prothya Biosolutions makes

The company produces life-saving plasma-derived medicines and offers plasma collection, fractionation, contract manufacturing, and technology transfer services.

Latest developments

Facilities

Prothya Biosolutions is headquartered in Brussels, Brussels. Public sources also reference these locations:

Company details

Prothya combined over 60 years of plasma industry experience from its predecessor organizations and operates facilities in Brussels, Belgium, and Budapest, Hungary, alongside its Amsterdam headquarters. Prothya Biosolutions was founded in 2021, has an estimated 1,000-5,000 employees, and is headquartered in Brussels, Brussels.

Frequently asked questions

What does Prothya Biosolutions do?

Prothya Biosolutions is a European biotechnology company headquartered in Brussels, Belgium, founded in 2021 through the merger of Plasma Industries Belgium and Sanquin Plasma Products. The company employs 1,000–5,000 people and generates an estimated $100–250 million in revenue. It specializes in blood plasma collection, processing, and fractionation to produce plasma-derived medicinal products including albumin, immunoglobulins, and coagulation factors for medical, automotive, and industrial-equipment sectors. In October 2025, Accord Plasma B.V. acquired the company.

Where is Prothya Biosolutions headquartered?

Prothya Biosolutions is headquartered in Brussels, Brussels (1 Montoyerstraat, Brussels, Brussels, 1000).

When was Prothya Biosolutions founded?

Prothya Biosolutions was founded in 2021.

How big is Prothya Biosolutions?

Prothya Biosolutions has an estimated 1,000-5,000 employees, with revenue in the $100-250M range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Brussels, Brussels (HQ)Headquarters · Belgium
Brussels, Brussels (HQ)1 Montoyerstraat, Brussels, Brussels, 1000, BelgiumHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.